Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
Week 40 Full Time or Part Time? Full Time Shift Day Work Schedule Summary VP Area U of U Health - Academics Department 01337 - Molecular Medicine Program Location Campus City Salt Lake City, UT Type
-
, HRSA, or NSF, is highly desirable. Candidates are expected to have a PhD degree from a quantitative field, such as Biomedical informatics, computer science, engineering, computational biology, applied
-
primary duty consisting of research-related work. The individual will focus on protein biochemistry and structural biology in cancer-relevant projects. Required to meet FLSA threshold to be paid on a
-
of Medicine, ranked among the top 30 public research universities in the nation, located in the foothills overlooking Salt Lake City. The focus of the available project within the broader research program is to
-
limited to cardiology, genetics, molecular and cellular biology, computer science, and human stem cell biology. The successful applicant will have a strong track record of accomplishment and prior
-
contributions are expected. This position will evaluate novel combinations of anticancer agents and novel small molecules under investigation as novel anticancer agents and explore tumor biology in multiple tumor
-
retina, calcium fluorescence imaging, virus-mediated cell targeting, immunohistochemistry, large-scale data analysis, and computational modeling. Successful applicant will have excellent scientific
-
vivo retina, calcium fluorescence imaging, virus-mediated cell targeting, immunohistochemistry, large-scale data analysis, and computational modeling. Successful applicant will have excellent scientific
-
, Biochemistry, Molecular Biology, or related fields. Applicants should have high proficiency in general cell biology and molecular biology techniques, including cell culture, western blots, cellular assays
-
Preferences • PhD/MD, or equivalent degree in systems biology, toxicology, immunology • Record of scientific achievement through publications and presentations • Independency with next-generation sequencing